"10.1371_journal.pone.0120866","plos one","2015-08-28T00:00:00Z","Olav Dalgard; Michelle Martinot-Peignoux; Hans Verbaan; Kristian Bjøro; Helmer Ring-Larsen; Patrick Marcellin","Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway; Institut National de la Santé et de la Recherche Médicale, U-773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, Université Paris VII, Paris, France; Medical Department, Malmø University Hopsital, Malmø, Sweden; Clinic for specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Department of Pharmacology and Pharmacotherapy, University of Copenhagen, Copenhagen, Denmark; Service d'Hépatologie, Hŏpital Beaujon, Clichy, France","Conceived and designed the experiments: OD MMP PM. Performed the experiments: OD MMP. Analyzed the data: MMP. Contributed reagents/materials/analysis tools: OD KB HV HRL. Wrote the paper: OD MMP.","O Dalgard has received grants from Merck, Medivir and Gilead and sitting on advisory boards for the following companies: Medivir, Abbvie, Merck and janssen and Cilag. P Marcellin has received grants from Rochem Gilead, Bristol Myers Squibbs, Novartis, MSD and Alios BioPharma and gives advice to Roche, Gilead, BMS, Vertex, Novartis, MSD and Abbvie. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","08","Olav Dalgard","OD",6,TRUE,3,2,1,2,TRUE,FALSE,FALSE,0,NA,FALSE
